Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells?

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Stem Cell Biology

Background:

• Mesenchymal stem cells (MSCs) are known for immune privilege.
• Investigating MSCs' potential to create a suppressive microenvironment for coinjected human embryonic stem cells (hESCs).

Purpose of the Study:

• To assess if MSCs mitigate rejection of coinjected hESCs after myocardial infarction.
• To evaluate the functional preservation and cellular changes following cell transplantation.

Main Methods:

• Adult immunocompetent rats with myocardial infarction received hESCs, MSCs, hESC + MSC, or control medium.
• Echocardiography assessed left ventricle function; hearts were analyzed for cell engraftment, immune cell infiltration, fibrosis, and angiogenesis.

Main Results:

• Left ventricle ejection fraction was significantly higher in hESC and hESC + MSC groups compared to controls.
• Engrafted cells expressed endothelial, smooth muscle, and cardiac markers, especially in the MSC group.
• MSC transplantation increased FoxP3 infiltration, suggesting a potential immunomodulatory role, but overall immune cell infiltration was similar across groups.

Conclusions:

• Co-transplantation of hESCs and MSCs offered superior functional preservation compared to single-cell treatments.
• The beneficial effects of MSCs appeared primarily mediated by trophic support to host tissues, with limited evidence of direct immunosuppression.